A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation

Description

The purpose of this study is to test if a nerve block procedure called a stellate ganglion block can help decrease the chance of atrial fibrillation after surgery. Atrial fibrillation is the abnormal, fast beating of the upper chambers of the heart. Stellate ganglion blockade has shown to decrease other types of abnormal heart rhythms as well as decrease the chance of atrial fibrillation.

Conditions

Atrial Fibrillation

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to test if a nerve block procedure called a stellate ganglion block can help decrease the chance of atrial fibrillation after surgery. Atrial fibrillation is the abnormal, fast beating of the upper chambers of the heart. Stellate ganglion blockade has shown to decrease other types of abnormal heart rhythms as well as decrease the chance of atrial fibrillation.

Stellate Ganglion Blockade for the Prevention of Atrial Fibrillation After Cardiac Surgery: A Randomized Placebo-Controlled Trial

A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation

Condition
Atrial Fibrillation
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient presenting for cardiac surgery at the Mayo Clinic in Rochester, Minnesota.
  • * Patients scheduled to undergo mitral or aortic valve surgery with or without coronary artery bypass grafting.
  • * Patients with a history of permanent atrial fibrillation, left or right ventricular assist device implantation or explantation.
  • * Patients with procedures not requiring cardiopulmonary bypass.
  • * Patients with procedures requiring deep hypothermic circulatory arrest.
  • * Patients with active infection or sepsis.
  • * Pre-operative immunosuppressive medication use (including steroid use).
  • * Pre-operative anti-arrhythmic medication use (aside from beta-blockers).
  • * Patients with Immunodeficiency syndrome.
  • * Patients with known neurologic disorder.
  • * Patients requiring left internal jugular central line placement.
  • * Performance of Maze procedures or left atrial appendage ligation procedures will not exclude patients from potential enrollment as atrial fibrillation still occurs postoperatively while the scarring from the Maze procedure forms.

Ages Eligible for Study

60 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Erica Wittwer, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2025-12